NCT01234675View on ClinicalTrials.gov

The Effects of Milnacipran on Sleep Disturbance in Fibromyalgia

PHASE4CompletedINTERVENTIONAL
Enrollment

19

Participants

Timeline

Start Date

November 30, 2010

Primary Completion Date

February 28, 2014

Study Completion Date

February 28, 2014

Conditions
Sleep DisordersFibromyalgiaSleep
Interventions
DRUG

Milnacipran

50 mg twice daily

DRUG

Placebo

50 mg twice daily

Trial Locations (1)

44130

Cleveland Sleep Research Center, Middleburg Heights

Sponsors

Collaborators (1)

Forest Laboratories
All Listed Sponsors
collaborator

Forest Laboratories

INDUSTRY

lead

Mansoor Ahmed M.D.

OTHER